Author | Shilpa Gupta, MD | OncLive

Author | Shilpa Gupta, MD


Dr. Gupta on Challenges With Perioperative Immunotherapy in Bladder Cancers

July 08, 2020


Shilpa Gupta, MD, discusses challenges with ​perioperative immunotherapy in bladder cancer.

Dr. Gupta on Neoadjuvant Versus Adjuvant Immunotherapy in Urothelial Carcinoma

June 16, 2020


Shilpa Gupta, MD, discusses the potential utility of neoadjuvant versus adjuvant immunotherapy in urothelial carcinoma.

Dr. Gupta on BLASST-1 Results in Muscle-Invasive Bladder Cancer

February 13, 2020


Shilpa Gupta, MD, medical oncologist, Department of Hematology and Medical Oncology, Cleveland Clinic, discusses the results of the phase II BLASST-1 trial, which is evaluating nivolumab, gemcitabine, and cisplatin in patients with muscle-invasive bladder cancer who are undergoing cystectomy.

Dr. Gupta on Challenges of Identifying Biomarkers in Bladder Cancer

October 15, 2019


Shilpa Gupta, MD, discusses the challenges of identifying predictive biomarkers in bladder cancer.